HU228208B1 - Palladium-substituted bacteriochlorophyll derivatives and use thereof - Google Patents

Palladium-substituted bacteriochlorophyll derivatives and use thereof Download PDF

Info

Publication number
HU228208B1
HU228208B1 HU0105411A HUP0105411A HU228208B1 HU 228208 B1 HU228208 B1 HU 228208B1 HU 0105411 A HU0105411 A HU 0105411A HU P0105411 A HUP0105411 A HU P0105411A HU 228208 B1 HU228208 B1 HU 228208B1
Authority
HU
Hungary
Prior art keywords
compound
formula
compounds
pharmaceutical composition
bpheid
Prior art date
Application number
HU0105411A
Other languages
English (en)
Hungarian (hu)
Inventor
Avigdor Scherz
Yoram Salomon
Alexander Brandis
Hugo Scheer
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of HUP0105411A2 publication Critical patent/HUP0105411A2/hu
Publication of HUP0105411A3 publication Critical patent/HUP0105411A3/hu
Publication of HU228208B1 publication Critical patent/HU228208B1/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU0105411A 1998-12-09 1999-12-09 Palladium-substituted bacteriochlorophyll derivatives and use thereof HU228208B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98403110 1998-12-09
PCT/IL1999/000673 WO2000033833A1 (en) 1998-12-09 1999-12-09 Palladium-substituted bacteriochlorophyll derivatives and use thereof

Publications (3)

Publication Number Publication Date
HUP0105411A2 HUP0105411A2 (hu) 2002-04-29
HUP0105411A3 HUP0105411A3 (en) 2003-12-29
HU228208B1 true HU228208B1 (en) 2013-01-28

Family

ID=8235584

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105411A HU228208B1 (en) 1998-12-09 1999-12-09 Palladium-substituted bacteriochlorophyll derivatives and use thereof

Country Status (22)

Country Link
US (1) US6569846B1 (https=)
EP (1) EP1137411B1 (https=)
JP (1) JP4796227B2 (https=)
CN (1) CN1160069C (https=)
AT (1) ATE347554T1 (https=)
AU (1) AU771292B2 (https=)
BR (1) BRPI9916096B8 (https=)
CA (1) CA2353554C (https=)
CY (1) CY1106450T1 (https=)
DE (1) DE69934328T2 (https=)
DK (1) DK1137411T3 (https=)
ES (1) ES2277454T3 (https=)
HK (1) HK1040638B (https=)
HU (1) HU228208B1 (https=)
IL (1) IL143591A0 (https=)
NO (1) NO331426B1 (https=)
NZ (1) NZ512093A (https=)
PL (1) PL201172B1 (https=)
PT (1) PT1137411E (https=)
RU (1) RU2234508C2 (https=)
SI (1) SI1137411T1 (https=)
WO (1) WO2000033833A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
EP1318807A4 (en) * 2000-08-11 2008-02-20 Ceramoptec Gmbh LIGHT-SENSITIVE OINTMENT
EP1277470A1 (fr) * 2001-07-17 2003-01-22 Steba Biotech N.V. Formulation galénique injectable pour utilisation dans un diagnostic ou une thérapie photodynamique et son procédé de préparation
AU2003230164B2 (en) * 2002-05-08 2008-05-01 Yeda Research And Development Co. Ltd. Sensitized online BOLD-MRI imaging method
JP4529344B2 (ja) * 2002-06-03 2010-08-25 ニプロ株式会社 腫瘍組織の酸素濃度を上昇させるためのポルフィリン酸素輸液製剤
AU2003249742A1 (en) * 2002-07-02 2004-01-23 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
RU2257898C1 (ru) * 2004-03-22 2005-08-10 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Фотосенсибилизатор, липосомальная форма фотосенсибилизатора и способ проведения фотодинамической терапии
DK1753457T3 (en) * 2004-06-07 2016-12-05 Yeda Res & Dev Cationic bakterieklorofylderivater and uses
GB2415372A (en) * 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
US20060222592A1 (en) * 2005-04-05 2006-10-05 Clemens Burda Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications
EP2244787A1 (en) * 2008-01-28 2010-11-03 Yeda Research And Development Company Ltd. Endoscopic imaging photodynamic therapy system and methods of use
CA2717060C (en) 2008-02-27 2016-11-01 Avigdor Scherz Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
US20110070154A1 (en) * 2008-08-13 2011-03-24 Hyde Roderick A Artificial cells
GB0819594D0 (en) 2008-10-24 2008-12-03 Univ Coimbrra Process
EP2425873A1 (fr) 2010-09-07 2012-03-07 Steba Maor SA Modélisation de l'action d'une fibre optique dans un traitement par therapie photodynamique, et assistance à la planification d'un tel traitement
CN103405769A (zh) * 2013-03-07 2013-11-27 北京亿仁赛博医疗科技研发中心有限公司 光敏剂在制备治疗疾病的病毒灭活药物中的应用
PL2971026T3 (pl) 2013-03-11 2021-06-14 Tookad Ip Sarl Sposób wytwarzania bakteriochlorofilu a
BR112015023568B8 (pt) 2013-03-15 2024-01-02 Ann Mcfarland Sherri Composto à base de metal como composto fotodinâmico
RU2021110230A (ru) 2016-04-10 2021-05-26 Йеда Рисерч Энд Дивелопмент Ко. Лтд. Комбинированные способы терапии для лечения злокачественной опухоли
US10933134B2 (en) 2017-03-16 2021-03-02 Memorial Sloan Kettering Cancer Center Combination therapies for treatment of cancer
IL311461B1 (en) * 2024-03-13 2026-01-01 Impact Biotech Ltd Process for preparing palladium-bacteriophophorbide derivatives and their alkali metal salts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002962A (en) 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
IL102645A (en) * 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
RU2063971C1 (ru) * 1993-11-05 1996-07-20 Московская государственная академия тонкой химической технологии им.М.В.Ломоносова Способ получения производного гематопорфирина
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
WO2000033833A1 (en) 2000-06-15
EP1137411B1 (en) 2006-12-06
NO331426B1 (no) 2011-12-27
JP4796227B2 (ja) 2011-10-19
EP1137411A4 (en) 2003-04-23
PT1137411E (pt) 2007-02-28
NZ512093A (en) 2003-04-29
US6569846B1 (en) 2003-05-27
PL348201A1 (en) 2002-05-06
DE69934328T2 (de) 2007-07-19
JP2002531497A (ja) 2002-09-24
CY1106450T1 (el) 2011-10-12
NO20012807D0 (no) 2001-06-07
HK1040638B (en) 2007-06-15
AU1583400A (en) 2000-06-26
HUP0105411A2 (hu) 2002-04-29
BR9916096B1 (pt) 2013-11-19
BR9916096A (pt) 2001-11-13
ATE347554T1 (de) 2006-12-15
RU2234508C2 (ru) 2004-08-20
CA2353554C (en) 2011-04-26
CN1334728A (zh) 2002-02-06
DE69934328D1 (de) 2007-01-18
IL143591A0 (en) 2002-04-21
EP1137411A1 (en) 2001-10-04
CA2353554A1 (en) 2000-06-15
PL201172B1 (pl) 2009-03-31
HK1040638A1 (en) 2002-06-21
BRPI9916096B8 (pt) 2021-05-25
AU771292B2 (en) 2004-03-18
NO20012807L (no) 2001-08-08
ES2277454T3 (es) 2007-07-01
DK1137411T3 (da) 2007-03-26
HUP0105411A3 (en) 2003-12-29
CN1160069C (zh) 2004-08-04
SI1137411T1 (sl) 2007-10-31

Similar Documents

Publication Publication Date Title
HU228208B1 (en) Palladium-substituted bacteriochlorophyll derivatives and use thereof
Li et al. Role of ferroptosis in the process of acute radiation-induced lung injury in mice
Xu et al. 5-(3, 4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1, 2, 4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress
Ma et al. In vitro production of huperzine A, a promising drug candidate for Alzheimer’s disease
Ittadwar et al. Novel umbelliferone phytosomes: development and optimization using experimental design approach and evaluation of photo-protective and antioxidant activity
KR100544376B1 (ko) 면역증강성 및 전이억제성 발효된 식물성 추출물, 약제학적 조성물 및 이의 용도
KR101344303B1 (ko) 표적 치료에 관한 종양에 선택성이 있는 콘쥬게이트
KR100379323B1 (ko) 카테킨을 포함하는 관상동맥 재협착 예방 및 치료용 약학조성물
Shao et al. Biotinylated curcumin as a novel chemosensitizer enhances naphthalimide-induced autophagic cell death in breast cancer cells
JP2011503186A (ja) 抗新生物活性を有するナンキョクコメススキ(DeschampsiaantarcticaDesv.)の新規抽出物
AU785489B2 (en) Method for detecting and killing epithelial cancer cells
Stan et al. ARTEMISIA ANNUA L. EXTRACT: A NEW PHYTOPRODUCT WITH SOD-LIKE AND ANTITUMOUR ACTIVITY.
Zhang et al. Photodynamic efficiency of a chlorophyll-a derivative in vitro and in vivo
Silva et al. Toxicological and pharmacological evaluation of Discaria americana Gillies & Hook (Rhamnaceae) in mice
CA2165836C (fr) Utilisation des derives du rosmanol pour la fabrication des medicaments anti-radicalaires et/ou antilipoperoxydantes et/ou hepatotropes
CN103749456A (zh) 二萜生物碱类化合物及制剂在抑防作物病毒病害中的应用
Pérez-González et al. Anti-inflammatory, antioxidant, and acute toxicity of Brugmansia arborea extracts from wild plants and shoots obtained by indirect organogenesis. A thermographic assay to anti-inflammatory evaluation
Son et al. Neuroprotective effect of scopoletin from Angelica dahurica on oxygen and glucose deprivation-exposed rat organotypic hippocampal slice culture
KR102117560B1 (ko) 켈락톤 및 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 암 예방 및 치료용 조성물
US20030017158A1 (en) Method for detecting and killing epithelial cancer cells
Qu et al. Orally engineered liver-targeted garlic exosome-like nanovesicles for astaxanthin precise delivery against alcoholic liver disease in mice
CN117414378A (zh) 富硒辣木在抗肿瘤中的应用
CN107648221A (zh) 大萼香茶菜乙素二乙酰化物的药物新用途
Khan et al. Investigation of Polymeric Nanoparticles Encapsulating Natural Sources for Targeting of Cancer
Dutta et al. Effect of the leaves of Psidium guajava Linn. on experimentally induced colitis in animal models